Engineering Fundamentals in Life Science | |||
| Session 336 - Cardiovascular and Cancer (I) | |||
| This session will highlight engineering approaches to problems in cancer, cardiovascular and other diseases. Emphasis will be on studies of transport, cell and tissue mechanics, heat transfer, and kinetics applied specifically to the areas of tumor biology, metastasis, and the circulation. Topics may span length-scales from molecular to organismal physiology, involving computational and/or experimental methods. Sample topics include: - angiogenesis - atherosclerosis - cancer cell adhesion and migration - cancer cell signaling - intracellular metabolism - diabetes - gene therapies – novel therapeutic strategies - ischemia / reperfusion injury - models of tumor development - sickle cell disease - thrombosis/fibrinolysis - tumor pharmacokinetics and drug delivery. | |||
| Chair: | Neil S. Forbes | ||
| CoChair: | Edgar O'Rear III | ||
| 336a | Modeling Delivery of Supplemental Nitric Oxide in Resistance Vessels Daniel R. Hyduke, James C. Liao | ||
| 336b | A Novel, Quantifiable Three-Dimensional Model of Melanoma Invasion Cyrus M. Ghajar, Katherine S. Blevins, Vinod A. Suresh, Christopher B. Raub, Steven C. George, Andrew J. Putnam | ||
| 336c | Parsing the Crosstalk between Prominent Oncogenic Signaling Pathways Nicholas A. Graham, Anand R. Asthagiri | ||
| 336d | Mitochondria Depolarizing Peptides Sensitize Prostate Cancer Cells to Death Receptor Mediated Apoptosis Kaushal Rege, Martin L. Yarmush | ||
| Break | |||
| 336e | Fibrin-Cd44v Binding Interferes with Platelet-Colon Carcinoma Cell Adhesion under High Shear Conditions Christina S. Alves, Susan L. Napier, Parag Pawar, Konstantinos Konstantopoulos | ||
| 336f | Ultrasound-Enhanced Chemotherapy and Gene Delivery for Gliosarcoma Cells Vladimir G. Zarnitsyn, Pavel Kamaev, Mark R. Prausnitz | ||
| 336g | Tnf-a Based Accentuation of Cryoinjury for the Treatment of Prostate Cancer-Dose, Delivery and Response Raghav Goel, David Swanlund, James Coad, Guilio Paciotti, John Bischof | ||
See more of Food, Pharmaceutical & Bioengineering Division